We have located links that may give you full text access.
Controlled Clinical Trial
Journal Article
Multicenter Study
Long-term mortality following peptic ulcer perforation in the PULP trial. A nationwide follow-up study.
Scandinavian Journal of Gastroenterology 2013 Februrary
OBJECTIVE: Morbidity and mortality following perforated peptic ulcer (PPU) remain substantial. In the recently published PULP trial, 30-day mortality in patients surgically treated for PPU decreased from 27% to 17% following the implementation of a perioperative care protocol based on The Surviving Sepsis Guidelines. The objective of the present study was to evaluate long-term mortality in the PULP trial intervention and control cohort.
DESIGN: nationwide follow-up study of a multicenter, non-randomized, clinical trial with external controls.
SETTING: Danish patients surgically treated for PPU between 1 January 2008 and 31 December 2009.
PATIENTS: 117 patients in the intervention group and 512 in the control group.
INTERVENTION: a perioperative care protocol based on The Surviving Sepsis Guidelines.
OUTCOME MEASURES: 60-day, 90-day, 180-day, 1-year, and 2-year mortality rates.
STATISTICAL ANALYSIS: survival statistics.
RESULTS: Baseline characteristics, clinical, and perioperative data were in general, similar in the intervention and control group. Sixty days postoperatively, the originally observed difference in 30-day mortality had diminished (25% vs. 30%, p = 0.268). After 180 days, the mortality difference was reduced additionally (31% vs. 33%, p = 0.645), and one year postoperatively, a mortality difference was no longer present (36% in both groups, p = 0.993). Two years postoperatively, the mortality rate in the intervention group was 44%, as compared to 40% in the control group (p = 0.472).
CONCLUSIONS: The survival benefit associated with a perioperative care protocol in patients treated for PPU decreases progressively after 30 days and is no longer present after one year.
REGISTRATION NUMBER: NCT00624169 ( https://www.clinicaltrials.gov ).
DESIGN: nationwide follow-up study of a multicenter, non-randomized, clinical trial with external controls.
SETTING: Danish patients surgically treated for PPU between 1 January 2008 and 31 December 2009.
PATIENTS: 117 patients in the intervention group and 512 in the control group.
INTERVENTION: a perioperative care protocol based on The Surviving Sepsis Guidelines.
OUTCOME MEASURES: 60-day, 90-day, 180-day, 1-year, and 2-year mortality rates.
STATISTICAL ANALYSIS: survival statistics.
RESULTS: Baseline characteristics, clinical, and perioperative data were in general, similar in the intervention and control group. Sixty days postoperatively, the originally observed difference in 30-day mortality had diminished (25% vs. 30%, p = 0.268). After 180 days, the mortality difference was reduced additionally (31% vs. 33%, p = 0.645), and one year postoperatively, a mortality difference was no longer present (36% in both groups, p = 0.993). Two years postoperatively, the mortality rate in the intervention group was 44%, as compared to 40% in the control group (p = 0.472).
CONCLUSIONS: The survival benefit associated with a perioperative care protocol in patients treated for PPU decreases progressively after 30 days and is no longer present after one year.
REGISTRATION NUMBER: NCT00624169 ( https://www.clinicaltrials.gov ).
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app